Pharma Foods International Co.Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharma Foods International Co.Ltd with three other
pharmaceutical manufacturers in Asia:
China Regenerative Medicine International Ltd
of Hong Kong
sales of 356.99 million Hong Kong Dollars [US$45.52 million]
of which 51%
was Medical equipment),
Zhejiang Wolwo Bio Pharmaceutical Co Ltd
(385.58 million Chinese Renmimbi [US$60.86 million]
of which 99%
was Pharmaceutical Manufacturing), and
Komipharm International Company Limited
based in South Korea
(36.64 billion Korean Won [US$34.22 million]
of which 100%
was Animal Pharmaceutical).
During the year ended July of 2017, sales at
Pharma Foods International Co.Ltd were ¥4.72 billion (US$44.53 million).
increase of 36.5%
versus 2016, when the company's sales were ¥3.46 billion.
This was the fifth consecutive year of sales increases at Pharma Foods International Co.Ltd
(and since 2012, sales have increased a total of 286%).
Sales of Functional Products(Online Business) saw an increase
66.6% in 2017, from
¥2.07 billion to ¥3.44 billion.
Not all segments of Pharma Foods International Co.Ltd experienced an increase in sales in 2017:
sales of Biomedical fell 22.1% to ¥43.38 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
Pharma Foods International Co.Ltd also experienced decreases in sales in
Functional Material (down 7.6% to ¥1.24 billion)